Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Inno-206
MALT Lymphoma
SWOG Cancer Research Network
P2
BB
(68)
Inno-206
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Inno-206
Wilms Tumor
Children's National Research Institute
P2
BB
(68)
Ipilimumab
Recurrent Hodgkin Lymphoma
Dana-Farber Cancer Institute
P2
BB
(68)
Ipilimumab
Recurrent Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
BB
(68)
Irinotecan
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)
P2
BB
(68)
Irinotecan
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
P2
BB
(68)
Mitoxantrone
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Institut de Recherches Internationales Servier
P2
BB
(68)
Monomethyl Fumarate
Acute Undifferentiated Leukemia
Masonic Cancer Center, University of Minnesota
P2
BB
(68)
Monomethyl Fumarate
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer Center
P2
BB
(68)
Monomethyl Fumarate
Graft Versus Host Disease
City of Hope Medical Center
P2
BB
(68)
Obinutuzumab
MALT Lymphoma
University of Washington
P2
BB
(68)
Palbociclib
Colon Carcinoma
Lebanese University
P2
BB
(68)
Pembrolizumab
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P2
BB
(68)
Pembrolizumab
Primary Mediastinal Large B-Cell Lymphoma
Seda S. Tolu
P2
BB
(68)
PREDNISONE TABLETS
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
PREDNISONE TABLETS
MALT Lymphoma
SWOG Cancer Research Network
P2
BB
(68)
PREDNISONE TABLETS
Haematological Malignancy
National Cancer Institute (NCI)
P2
BB
(68)
PREDNISONE TABLETS
Plasmablastic Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Rapamycin
Lymphangioleiomyomatosis
University of Cincinnati
P2
BB
(68)
Recombinant Human Granulocyte Colony-Stimulating Factor
Myeloid Neoplasm
University of Washington
P2
BB
(68)
Regorafenib
Metastatic Colorectal Carcinoma
City of Hope Medical Center
P2
BB
(68)
Relatlimab
Neoplasm
Bristol-Myers Squibb
P2
BB
(68)
Romidepsin
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Walter Hanel
P2
BB
(68)
Romidepsin
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Showing 401 to 425 of 19,639 assets
Previous
Page 17 of 786
Next